<DOC>
	<DOCNO>NCT00961363</DOCNO>
	<brief_summary>The purpose study examine safety efficacy sitagliptin 100 mg every day ( q.d . ) improve hyperglycemia endothelial dysfunction subject impair glucose tolerance .</brief_summary>
	<brief_title>Effect Sitagliptin Impaired Glucose Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>1 . Chinese subject age 4065 year fast plasma glucose &lt; 100 mg/dL OGTT 2hour glucose 140199 mg/dL . 2 . Subjects judge otherwise general good health base medical history , physical examination , routine laboratory test . 3 . Subject understand study procedure , alternative treatment available risk involve study , voluntarily agree participate give write informed consent . 4 . Nonsterilized premenopausal female agrees receive pregnancy test confirm nonpregnancy status use adequate contraceptive method prevent pregnancy study period . Patient status confirm pregnancy test enrollment . 1 . Evidence diabetes ( FPG &gt; 125 mg/dL , OGTT 2hour glucose &gt; =200 mg/dL , current use antidiabetic agent , except history gestational diabetes ) . 2 . History intolerance hypersensitivity contraindication mention approved package insert ( appendix ) . 3 . Patient follow disorder within past 6 month : acute coronary syndrome ( e.g. , MI unstable angina ) , coronary artery intervention ( e.g. , CABG PTCA ) , stroke transient ischemic neurological disorder . 4 . Patient new worsen sign symptom coronary heart disease within past 3 month . 5 . Patient BMI &gt; 40 kg/m2 . 6 . Patient likely require 14 consecutive day repeat course pharmacologic dos corticosteroid . Note : inhale , nasal , topical corticosteroid permit . 7 . Patient likely require treatment immunosuppressive agent ( e.g. , cyclosporine , methotrexate ) . 8 . Advanced renal insufficiency ( estimate creatinine clearance &lt; 50 ml/min ) . 9 . Severe hepatic insufficiency ( ChildPugh score &gt; 9 , see Appendix ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>